Knight Therapeutics Inc. (GUD.TO)

CAD 5.21

(-0.19%)

Revenue Summary of Knight Therapeutics Inc.

  • Knight Therapeutics Inc.'s latest annual revenue in 2023 was 328.19 Million CAD , up 11.8% from previous year.
  • Knight Therapeutics Inc.'s latest quarterly revenue in 2024 Q2 was 95.57 Million CAD , up 10.36% from previous quarter.
  • Knight Therapeutics Inc. reported a annual revenue of 293.56 Million CAD in annual revenue 2022, up 20.57% from previous year.
  • Knight Therapeutics Inc. reported a annual revenue of 243.47 Million CAD in annual revenue 2021, up 22.03% from previous year.
  • Knight Therapeutics Inc. reported a quarterly revenue of 86.6 Million CAD for 2024 Q1, up 16.72% from previous quarter.
  • Knight Therapeutics Inc. reported a quarterly revenue of 89.9 Million CAD for 2023 Q2, up 8.85% from previous quarter.

Annual Revenue Chart of Knight Therapeutics Inc. (2023 - 2013)

Historical Annual Revenue of Knight Therapeutics Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 328.19 Million CAD 11.8%
2022 293.56 Million CAD 20.57%
2021 243.47 Million CAD 22.03%
2020 199.51 Million CAD 320.39%
2019 47.46 Million CAD 279.69%
2018 12.5 Million CAD 44.78%
2017 8.63 Million CAD 45.35%
2016 5.94 Million CAD 472.81%
2015 1.03 Million CAD 183.86%
2014 365.32 Thousand CAD 0.0%
2013 - CAD 0.0%

Peer Revenue Comparison of Knight Therapeutics Inc.

Name Revenue Revenue Difference
Aurora Cannabis Inc. 270.28 Million CAD -21.429%
Avicanna Inc. 16.79 Million CAD -1854.556%
Avant Brands Inc. 26.34 Million CAD -1145.821%
Cardiol Therapeutics Inc. - CAD -Infinity%
Crescita Therapeutics Inc. 17.52 Million CAD -1773.068%
MediPharm Labs Corp. 33.06 Million CAD -892.677%
OrganiGram Holdings Inc. 149.2 Million CAD -119.965%
Canopy Growth Corporation 297.14 Million CAD -10.45%
Willow Biosciences Inc. 1.17 Million CAD -27903.328%
Auxly Cannabis Group Inc. 101.07 Million CAD -224.699%